Search Results 591-600 of 14943 for Dental zirconium
... oral therapy) for 90 days prior to Baseline. Subject has pulmonary veno-occlusive disease. Malignancy diagnosed and/or treated within 5 years prior to ...
Will oral supplementation with Omega 3 free fatty acids in obese Barrett's esophagus subjects downregulate pro-neoplastic and pro-inflammatory pathways in ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...
The purpose of this study is to evaluate the effectiveness and safety of oral PRN1008 in moderate to severe pemphigus. Participation eligibility. Participant ...
Are unable to take oral medication OR have malabsorption syndrome or any other uncontrolled gastrointestinal condition (eg, nausea, diarrhea, vomiting) that ...
Current use of oral corticosteroids, with the exception of inhaled or topical steroids. Dexamethasone will be given only in combination with bortezomib on ...
... (oral, injectable, or implantable), intrauterine device, intrauterine hormone ... Patients with active, known, or suspected auto-immune disease or a syndrome that ...
Complete your Oral Qualifying Exam by Oct. 1. Complete Thesis Advisory Committee (TAC) progress reports by Jan. 1 and July 1. (You must be logged into the Mayo ...
The purpose of this study is to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.
Patients with mild claustrophobia are eligible and have the option to take 1mg oral Lorazepam prior to the MRI, if needed;; Allergy to gadolinium-containing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.